pI: 7.4565 |
Length (AA): 626 |
MW (Da): 72264 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 171 | 6fk1 (A) | 1 | 164 | 76.00 | 0 | 1 | 1.9408 | -1.35 |
1 | 171 | 2igv (A) | 1 | 171 | 80.00 | 0 | 1 | 2.0638 | -1.78 |
2 | 171 | 6hmz (X) | 2 | 171 | 75.00 | 0 | 1 | 2.01695 | -1.87 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_126792)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G55920 | Cyclophilin-like peptidyl-prolyl cis-trans isomerase family protein |
Arabidopsis thaliana | AT2G21130 | peptidyl-prolyl cis-trans isomerase CYP19-2 |
Arabidopsis thaliana | AT4G34870 | rotamase cyclophilin 5 |
Arabidopsis thaliana | AT4G38740 | peptidyl-prolyl cis-trans isomerase CYP1 |
Babesia bovis | BBOV_IV005000 | cyclophilin, putative |
Brugia malayi | Bm1_46745 | cyclophilin-type peptidyl-prolyl cis-trans isomerase-3, Bmcyp-3 |
Brugia malayi | Bm1_55850 | cyclophilin-type peptidyl-prolyl cis-trans isomerase-2, Bmcyp-2 |
Candida albicans | CaO19.13826 | Cyclophilin type peptidyl-prolyl cis-trans isomerase similar to S. cerevisiae CPR1 (YDR155C) |
Candida albicans | CaO19_6472 | hypothetical protein |
Candida albicans | CaO19.6472 | Cyclophilin type peptidyl-prolyl cis-trans isomerase similar to S. cerevisiae CPR1 (YDR155C) |
Caenorhabditis elegans | CELE_Y75B12B.2 | Protein CYN-7 |
Caenorhabditis elegans | CELE_Y75B12B.5 | Protein CYN-3 |
Caenorhabditis elegans | CELE_Y49A3A.5 | Protein CYN-1 |
Caenorhabditis elegans | CELE_ZK520.5 | Protein CYN-2 |
Cryptosporidium hominis | Chro.20441 | 20k cyclophilin |
Cryptosporidium parvum | cgd2_4120 | 20k cyclophilin, putative |
Dictyostelium discoideum | DDB_G0282359 | cyclophilin-type peptidylprolyl cis-trans isomerase |
Drosophila melanogaster | Dmel_CG7768 | CG7768 gene product from transcript CG7768-RA |
Drosophila melanogaster | Dmel_CG9916 | Cyclophilin 1 |
Echinococcus granulosus | EgrG_000920600 | expressed protein |
Echinococcus multilocularis | EmuJ_000920600 | expressed protein |
Homo sapiens | 101060363 | peptidyl-prolyl cis-trans isomerase A-like |
Homo sapiens | ENSG00000108179 | peptidylprolyl isomerase F |
Homo sapiens | ENSG00000196262 | peptidylprolyl isomerase A (cyclophilin A) |
Homo sapiens | 650157 | peptidyl-prolyl cis-trans isomerase A-like |
Homo sapiens | 101928624 | peptidyl-prolyl cis-trans isomerase A-like |
Leishmania braziliensis | LbrM.33.1900 | cyclophilin 4, putative |
Leishmania braziliensis | LbrM.25.0790 | cyclophilin a |
Leishmania braziliensis | LbrM.23.0060 | cyclophilin 11, putative |
Leishmania donovani | LdBPK_331730.1 | cyclophilin, putative |
Leishmania donovani | LdBPK_230060.1 | cyclophilin, putative |
Leishmania donovani | LdBPK_250940.1 | cyclophilin a, putative |
Leishmania infantum | LinJ.23.0060 | cyclophilin 11, putative |
Leishmania infantum | LinJ.33.1730 | cyclophilin 4, putative |
Leishmania infantum | LinJ.25.0940 | cyclophilin a |
Leishmania major | LmjF.33.1630 | cyclophilin 4, putative |
Leishmania major | LmjF.23.0050 | cyclophilin 11, putative |
Leishmania major | LmjF.25.0910 | cyclophilin a |
Leishmania mexicana | LmxM.32.1630 | cyclophilin, putative |
Leishmania mexicana | LmxM.25.0910 | cyclophilin a |
Leishmania mexicana | LmxM.23.0050 | cyclophilin, putative,peptidyl-prolyl cis-trans isomerase, putative |
Loa Loa (eye worm) | LOAG_06740 | cyclophilin-type peptidyl-prolyl cis-trans isomerase-2 |
Loa Loa (eye worm) | LOAG_03625 | cyclophilin Ovcyp-2 |
Mus musculus | 268373 | peptidylprolyl isomerase A |
Mus musculus | ENSMUSG00000021868 | peptidylprolyl isomerase F (cyclophilin F) |
Neospora caninum | NCLIV_031040 | Peptidyl-prolyl cis-trans isomerase (EC 5.2.1.8), related |
Neospora caninum | NCLIV_019970 | Peptidyl-prolyl cis-trans isomerase A, related |
Oryza sativa | 4347920 | Os09g0571400 |
Oryza sativa | 4328121 | Os02g0121300 |
Onchocerca volvulus | OVOC9856 |
|
Onchocerca volvulus | OVOC11375 |
|
Plasmodium berghei | PBANKA_1216500 | peptidyl-prolyl cis-trans isomerase, putative |
Plasmodium falciparum | PF3D7_0322000 | peptidyl-prolyl cis-trans isomerase |
Plasmodium knowlesi | PKNH_0818800 | peptidyl-prolyl cis-trans isomerase, putative |
Plasmodium vivax | PVX_095135 | cyclophilin, putative |
Plasmodium vivax | PVX_220290 | unspecified product |
Plasmodium yoelii | PY03668 | peptidyl-prolyl cis-trans isomerase, cyclophilin-type |
Saccharomyces cerevisiae | YDR155C | peptidylprolyl isomerase CPR1 |
Schistosoma japonicum | Sjp_0001030 | ko:K01802 peptidylprolyl isomerase [EC5.2.1.8], putative |
Schistosoma mansoni | Smp_040130 | cyclophilin |
Schmidtea mediterranea | mk4.002269.05 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.002976.00 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.002269.03 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.004974.02 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.006784.02 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.008473.01 | Peptidyl-prolyl cis-trans isomerase |
Schmidtea mediterranea | mk4.002499.01 | Peptidyl-prolyl cis-trans isomerase |
Trypanosoma brucei gambiense | Tbg972.11.920 | cyclophilin a,cyclophilin type peptidyl-prolyl cis-trans isomerase |
Trypanosoma brucei gambiense | Tbg.972.2.250 | cyclophilin-type peptidyl-prolyl cis-trans isomerase, putative,cyclophilin, putative |
Trypanosoma brucei gambiense | Tbg.972.2.170 | cyclophilin-type peptidyl-prolyl cis-trans isomerase, putative,cyclophilin, putative |
Trypanosoma brucei gambiense | Tbg972.8.1650 | cyclophilin type peptidyl-prolyl cis-trans isomerase, putative,peptidyl-prolyl cis-trans isomerase, putative |
Trypanosoma brucei | Tb927.11.880 | cyclophilin a |
Trypanosoma brucei | Tb927.8.2000 | cyclophilin, putative |
Trypanosoma brucei | Tb927.2.1560 | peptidyl-prolyl cis-trans isomerase, putative |
Trypanosoma brucei | Tb927.2.1680 | peptidyl-prolyl cis-trans isomerase, putative |
Trypanosoma congolense | TcIL3000_0_06330 | cyclophilin a, putative |
Trypanosoma congolense | TcIL3000_8_2030 | peptidyl-prolyl cis-trans isomerase, putative |
Trypanosoma congolense | TcIL3000_0_06320 | cyclophilin a, putative |
Trypanosoma congolense | TcIL3000.11.810 | cyclophilin a, putative |
Trypanosoma cruzi | TcCLB.509499.10 | cyclophilin, putative |
Trypanosoma cruzi | TcCLB.509215.40 | peptidyl-prolyl cis-trans isomerase, putative |
Trypanosoma cruzi | TcCLB.510259.50 | 21 kDa cyclophilin, putative |
Trypanosoma cruzi | TcCLB.506925.300 | cyclophilin type peptidyl-prolyl cis-trans isomerase |
Trypanosoma cruzi | TcCLB.510947.50 | rotamase, putative |
Toxoplasma gondii | TGME49_230520 | cyclophilin 1, putative |
Toxoplasma gondii | TGME49_205700 | cyclophilin precursor |
Theileria parva | TP01_0244 | cyclophilin 1 |
Trichomonas vaginalis | TVAG_137880 | peptidyl-prolyl cis-trans isomerase A, ppia, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.03.0250 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.03.0250 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.03.0250 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.03.0250 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.8.2000 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.2000 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.2000 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.2000 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y75B12B.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_1216500 | Plasmodium berghei | Slow | plasmo |
TGME49_205700 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_230520 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_205700 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_230520 | Toxoplasma gondii | Essentiality uncertain | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Rattus norvegicus | Cyclophilin A | Compounds | References |
Homo sapiens | peptidylprolyl isomerase F | Compounds | References |
Plasmodium falciparum | peptidyl-prolyl cis-trans isomerase | Compounds | References |